pembrolizumab
Merck
['gyn', 'peacocc', 'clear,trial', 'clear,result', 'pembro', 'medsir']
promising results of peacocc trial presented by dr. . pembro monotherapy showed high efficacy in heavily pre-treated pts with advanced clear cell gynaecological cancer:
-pfs rate at 12w was 43.8%
-best orr was 25.0% [1 complete, 11 partial]
-1y dor rate 47.7% #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM